The Joint Corp.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $117.8M
- Price
- $8.44
- % Change (Daily % change from the live per-ticker quote feed.)
- +2.30%
- Volume
- 46.6K
About
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Quick stats
Shares outstanding14.1M
Computed float8.2M
Float / shares58.2%
Key info
SectorHealthcare
IndustryMedical - Care Facilities
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001612630
Websitehttps://www.thejoint.com
AI Summary
AI-generated1/50
majorbullishearnings
The Joint Corp. Reports Second Quarter 2026 Financial Results
The Joint Corp. delivered strong Q2 results with revenue rising 14% year-over-year to $15.2 million and consolidated net income increasing to $653,000. Free cash flow surged 152% to $1.9 million, reflecting the benefits of the company's transition to a pure-play franchisor model under its Joint 2.0 strategy.
The company returned capital through $677,000 in share repurchases and three regional developer buybacks, bolstering a balance sheet that holds $22.2 million in unrestricted cash. Despite operational improvements, system-wide sales declined 3.7% to $128.0 million.
Management reiterated its full-year 2026 guidance for system-wide sales of $519 million to $552 million and Adjusted EBITDA of $12.5 million to $13.5 million. The company signaled a focus on optimizing existing locations over expansion, noting that total clinic count is expected to decrease by year-end.
Red flags
- System-wide sales decreased 3.7% year-over-year to $128.0 million, indicating weakness at the franchise level despite company revenue growth
- Net income from continuing operations remained negative at $251,000, while consolidated net income was positive only due to $904,000 in income from discontinued operations
- Full-year 2026 clinic count expected to be lower than 2025 year-end due to closures and optimization efforts